| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/17/1997 | CA2242666A1 Ungulate embryonic stem-like cells, methods of making and using the cells to produce transgenic ungulates |
| 07/17/1997 | CA2242430A1 Calcium binding proteolipid compositions and methods |
| 07/17/1997 | CA2241564A1 Wsx receptor and ligands |
| 07/17/1997 | CA2241169A1 Inhibitors of madcam-1-mediated interactions and methods of use therefor |
| 07/17/1997 | CA2239366A1 Recombinase-mediated generation of adenoviral vectors |
| 07/16/1997 | EP0784093A1 Osteoprotegerin |
| 07/16/1997 | EP0783693A1 In vitro models of cns function and dysfunction |
| 07/16/1997 | EP0783584A1 Vectors and process for producing high purity 6,12-dideoxyerythromycin a by fermentation |
| 07/16/1997 | EP0783577A1 Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors and the use of such compounds in the treatment of neurological disorders and diseases |
| 07/16/1997 | EP0783576A1 Human alpha 4? receptor subunit of the gaba-a receptor |
| 07/16/1997 | EP0783575A1 Anti-sickling beta-globin protein, compositions and methods for treating sickle cell disease |
| 07/16/1997 | EP0783572A1 Promoter for the receptor tyrosine kinase, tie |
| 07/16/1997 | EP0783569A1 Monoclonal antibody to human cardiac myoglobin |
| 07/16/1997 | EP0783568A1 Fibroblasts for the treatment of muscular disorders |
| 07/16/1997 | EP0783567A1 Human galactokinase gene |
| 07/16/1997 | EP0783527A1 Cathepsin o2 protease |
| 07/16/1997 | EP0783526A1 Anti-receptor and growth blocking agents to the vitamin b12/transcobalamin ii receptor and binding sites |
| 07/16/1997 | EP0783524A1 Peptides and pharmaceutical compositions comprising them |
| 07/16/1997 | EP0783523A1 Gaba a? receptor epsilon subunit |
| 07/16/1997 | EP0783511A1 Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof |
| 07/16/1997 | EP0783510A1 Human potassium channel 1 and 2 proteins |
| 07/16/1997 | EP0783313A1 Cdr-grafted type iii anti-cea humanized mouse monoclonal antibodies |
| 07/16/1997 | EP0613497B1 Lymphoid cd30-antigen |
| 07/16/1997 | EP0584125B1 Truncated forms of the hepatocyte growth factor (hgf) receptor |
| 07/16/1997 | EP0552308B1 A culture device having a detachable cell or tissue growth surface |
| 07/15/1997 | US5648563 Retro-alpha-retinol derivative and uses of retro-alpha-retinol |
| 07/15/1997 | US5648477 Genetically engineered plant cells and plants exhibiting resistance to glutamine synthetase inhibitors, DNA fragments and recombinants for use in the production of said cells and plants |
| 07/15/1997 | US5648467 Human cytokine |
| 07/15/1997 | US5648466 Method for detecting bovine diarrhoea virus infection, nucleotide sequence encoding a protein induced by this virus infection and recombinant proteins and antigens relating thereto |
| 07/15/1997 | US5648301 Bioactive material template for in vitro synthesis of bone tissue |
| 07/15/1997 | US5648273 Hepatic growth factor receptor is the MET proto-oncogene |
| 07/15/1997 | US5648259 Polypeptides having NMDA receptor activity, nucleic acids encoding those polypeptides and applications |
| 07/15/1997 | US5648252 Supported polyionic hydrogels containing biologically active material |
| 07/15/1997 | US5648250 Tissue plasminogen activator |
| 07/15/1997 | US5648249 Increasing level of adpglucose pyrophosphorylase |
| 07/15/1997 | US5648248 Methods for producing differentiated cells from immature hematopoietic cells |
| 07/15/1997 | US5648239 Human camp-dependent protein kinase inhibitor homolog |
| 07/15/1997 | US5648238 Human protein kinase C inhibitor homolog |
| 07/15/1997 | US5648227 Method of detecting microorganisms |
| 07/15/1997 | US5648226 Isolated peptides derived from tumor rejection antigens, and their use |
| 07/15/1997 | US5648223 Methods for enriching breast tumor cells |
| 07/15/1997 | US5648220 Methods for labeling intracytoplasmic molecules |
| 07/15/1997 | US5648219 Immortalized dendritic cells |
| 07/15/1997 | US5648215 Telomerase diagnostic methods |
| 07/15/1997 | US5648212 Detection of inherited and somatic mutations of APC gene in colorectal cancer of humans |
| 07/15/1997 | US5648206 Lyophilization of cells |
| 07/15/1997 | US5648072 Methods of inducing gamma interferon and stimulating blood cell populations using natural killer stimulatory factor |
| 07/10/1997 | WO1997024452A2 Toxic-protein expressing viruses and producer cell lines |
| 07/10/1997 | WO1997024443A1 Viral recombinant pseudo-particles and vaccinal and anti-tumoral applications |
| 07/10/1997 | WO1997024440A1 Ob protein derivatives having prolonged half-life |
| 07/10/1997 | WO1997024438A1 Immunostimulatory composition and method |
| 07/10/1997 | WO1997024435A1 Genes and gene products related to werner's syndrome |
| 07/10/1997 | WO1997024434A1 Expansion of bone marrow stromal cells |
| 07/10/1997 | WO1997024144A1 Methods of preparing bone marrow stromal cells for use in gene therapy |
| 07/10/1997 | WO1997024137A1 HYBRID WITH INTERFERON-α AND AN IMMUNOGLOBULIN Fc LINKED THROUGH A NON-IMMUNOGENIC PEPTIDE |
| 07/10/1997 | WO1997024134A1 A pharmaceutical composition comprising plant worms and muirapuama |
| 07/10/1997 | WO1997024133A1 Method for preparation of active substances from nacre, resulting products, useful in medicinal applications |
| 07/10/1997 | WO1997024132A1 Allogeneic paracrine cytokine tumor vaccines |
| 07/10/1997 | WO1997015662A3 Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor |
| 07/10/1997 | WO1997012974A3 Kidney atp-dependent potassium channels |
| 07/10/1997 | CA2254791A1 Method for preparation of active substances from nacre, resulting products, useful in medicinal applications |
| 07/10/1997 | CA2241373A1 Compositions and methods for t-cell activation comprising gm-csf and tumor antigen fusion proteins |
| 07/10/1997 | CA2241280A1 Viral recombinant pseudo-particles and vaccinal and anti-tumoral applications |
| 07/10/1997 | CA2240257A1 A pharmaceutical composition comprising plant worms and muirapuama |
| 07/10/1997 | CA2239522A1 Hybrid with interferon-.alpha. and an immunoglobulin fc linked through a non-immunogenic peptide |
| 07/10/1997 | CA2238307A1 Ob protein derivatives having prolonged half-life |
| 07/09/1997 | EP0783038A1 Recombinant viral pseudoparticles and their applications as vaccines or as antitumour agents |
| 07/09/1997 | EP0783037A1 Polypeptides with a dopaminergic receptor (D2-R and D3-R) activity and use of these polypeptides to screen substances having a selective activity on these polypeptides |
| 07/09/1997 | EP0782630A1 Polycystic kidney disease gene |
| 07/09/1997 | EP0782628A1 Improvement of an expression vector for production of recombinant proteins |
| 07/09/1997 | EP0782627A1 Genetically altered t-cells |
| 07/09/1997 | EP0782625A1 Expression and export technology of proteins as immunofusins |
| 07/09/1997 | EP0782622A1 RIBOZYME TREATMENT OF DISEASES OR CONDITIONS RELATED TO LEVELS OF PLASMA LIPOPROTEIN (a) Lp(a)] BY INHIBITING APOLIPOPROTEIN (a) APO(a)] |
| 07/09/1997 | EP0782619A1 Novel pka-binding proteins and uses thereof |
| 07/09/1997 | EP0782618A2 Allelic variation of the serotonin 5ht 2c? receptor |
| 07/09/1997 | CN1154144A Isolated, tyrosinase derived peptides and uses thereof |
| 07/09/1997 | CN1154142A Transgenic fish in the treatment of diabetes |
| 07/09/1997 | CN1154140A Method of control of microorganism growth process |
| 07/08/1997 | US5646255 Reaction product of protein, succinimide derivative and tetrapeptide sequence of valine-histidine-leucine-threonine |
| 07/08/1997 | US5646043 Culturing a hematopoeitic stem cell composition |
| 07/08/1997 | US5646042 C-myb targeted ribozymes |
| 07/08/1997 | US5646041 Monoclonal antibody to herpes simplex virus and cell line producing same |
| 07/08/1997 | US5646035 Method for preparing an expanded culture and clonal strains of pancreatic, thyroid or parathyroid cells |
| 07/08/1997 | US5646034 Recombinant adeno-associated virus |
| 07/08/1997 | US5646033 African green monkey kidney cell lines useful for maintaining viruses and for preparation of viral vaccines |
| 07/08/1997 | US5646032 Recombinant foamy virus vectors for medicinal, and diagnostic uses, and processes for preparing recombinant foamy virus vectors |
| 07/08/1997 | US5646029 Genetically engineered replacement for products derived from plant gums such as guar and gum arabic |
| 07/08/1997 | US5646024 Genetically engineered plant cells and plants exhibiting resistance to glutamine synthetase inhibitors, DNA fragments and recombinants for use in the production of said cells and plants |
| 07/08/1997 | US5646011 Overcoming resistance of tumor cells to chemotheraputic agents, gene expression |
| 07/08/1997 | US5646008 Vertebrate apoptosis gene: compositions and methods |
| 07/08/1997 | US5646004 Methods for enriching fetal cells from maternal body fluids |
| 07/08/1997 | US5645999 Assays for compounds that modulate or alter cyclin E activity |
| 07/08/1997 | US5645997 Assay and treatment for demyelinating diseases such as multiple sclerosis, related hybridomas and monoclonal antibodies |
| 07/08/1997 | US5645986 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 07/08/1997 | US5645833 Inhibitor resistant serine proteases |
| 07/08/1997 | US5645829 Mesothelial cell gene therapy |
| 07/06/1997 | CA2186542A1 Composition and method for delivery of nucleic acids |
| 07/05/1997 | CA2194411A1 Staphylococcus aureus polynucleotides and sequences |
| 07/03/1997 | WO1997023636A1 Production of recombinant baculoviruses |
| 07/03/1997 | WO1997023632A1 A LONG QT SYNDROME GENE WHICH ENCODES KVLQT1 AND ITS ASSOCIATION WITH minK |